Articles Tagged with product liability

levin perconti zantac injury

Zantac and Generic Ranitidine May Be Harmful

The U.S. Food and Drug Administration (FDA) recently revealed that Zantac and generic varieties contain a chemical that could be linked to cancer, called

N-nitrosodimethylamine (NDMA). Concern erupted when private lab Valisure found the contaminant and alerted FDA officials of a problem stemming from the composition of the drug. Several large pharmacy chains and stores such as Walmart, Rite-Aid, CVS and Walgreens have since suspended the sales of Zantac branded heartburn medicines and generic versions that contain active ingredient ranitidine. Three drugmakers – Apotex, Sandoz and GlaxoSmithKline – have recalled generic versions.

product liability lawyers

FDA Releases 20 Years of “Hidden” Data Related to Medical Device Injuries and Deaths 

Serious medical complications and lifelong injuries, and even death, can result from a risky or wrong medical device. But a March 8, 2019 Kaiser Health News investigative report has led to the recent Food and Drug Administration (FDA) release of two decades worth of previously hidden data containing millions of malfunctions by medical devices and allowed some manufacturers to keep potential safety issues quiet.

Some of the FDA’s public reporting of adverse device outcomes were previously filed as an “alternative summary,” and included more than 5.7 million incidents hidden from the American people. This is risk information that could have been (and now will be) helpful for device prescribing doctors, medical researchers and life-saving knowledge for consumers and patients.

product liability

Johnson & Johnson’s Talc Powder Product Marketing Still Aimed at Minority Groups Despite Cancer Claims

Decades of questioning the use and dangers of cosmetic talc powder in health and personal hygiene products finally came to light in 2006, when the World Health Organization began classifying cosmetic talc as “possibly carcinogenic.” At the head of the issue was well-known consumer product company, Johnson & Johnson along with its signature Baby Powder products. Despite tests revealing that the talc J&J uses is possibly harmful to humans and its related health risks, the company continues to focus on selling the product focusing on its longtime consumers. These groups include African-Americans, fitness enthusiasts and overweight women who use the products as a genital antiperspirant and deodorant. The inexpensive products are being explicitly marketed to improve the livelihood of a group of innocent consumers misinformed from a company undeterred by the concern about the health effects and cancer risks of talc.

Consequently, these same minority and overweight women audiences are being struck with ovarian cancer or mesothelioma and now make up a large number of the plaintiffs alleging that J&J’s Baby Powder and Shower to Shower products were the cause. And in July of 2018, J&J was ordered to pay $4.69 billion to 22 women who had claimed that asbestos in the company’s talcum powder products caused them to develop ovarian cancer and failed to warn consumers about the risks associated with its use.

medical malpractice attorneys

FDA Says Surgical Mesh Manufacturers Must Stop Selling Unsafe Devices

On April 16, 2019, The U.S. Food and Drug Administration (FDA) ordered two manufacturers of three different vaginal mesh products to immediately stop selling and distributing their products for not meeting U.S. premarket standards for high risk devices. The FDA also said there was insufficient evidence that the mesh worked better than surgery to repair pelvic organ prolapse (POP).

The three vaginal mesh devices are:

pollution in chicago

Willowbrook Sterigenics Investigated for Emitting Invisible Cancer-Causing Gas to Residents and Workers

The U.S. Environmental Protection Agency (EPA) is headed to the neighborhood of one of Levin & Perconti’s founding partners, John Perconti, to perform “ambient air testing” at the Willowbrook Sterigenics facility in DuPage County. Sterigenics is a global company which runs contract business for sterilization services. The Willowbrook facility, currently at the center of a toxic emissions review, sterilizes medical devices such as syringes and surgical procedure kits. The emission in question, Ethylene Oxide (EtO), is a known carcinogen and airborne substance identified as troublesome and cancer-causing for residents and workers who are ongoingly exposed. In 2007, the EPA issued standards to reduce emissions of EtO from hospital and medical device sterilizers to protect workers and community residents from damaging air pollutants.

An August 2018 public report prepared by the U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry (ATSDR) titled “Evaluation of Potential Health Impacts for Ethylene Oxide Emissions” showed workers and residents who live nearby Sterigenics have been exposed to elevated airborne EtO concentrations. The ATSDR further concluded that “an elevated cancer risk exists for residents and off-site workers in the Willowbrook community surrounding the Sterigenics facility,” and that “these elevated risks present a public health hazard.” ATSDR officials have put forth the recommendation that Sterigenics “take immediate action to reduce EtO emissions at this facility.”

Lawyer Monthly - Legal Awards Winner
The National Trial Lawyers
Elder Care Matters Alliance
American Association for Justice
Fellow Litigation Counsel of America
Super Lawyers